BLC
CVS icon

Brown, Lisle/Cummings’s CVS Health CVS Stock Holding History

Brown, Lisle/Cummings’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$985K Buy
13,708
+104
+0.8% +$8.01K 0.25% 92
2025
Q4 		$1.08M Buy
13,604
+731
+6% +$57.6K 0.27% 91
2025
Q3 		$970K Sell
12,873
-205
-2% -$14K 0.25% 98
2025
Q2 		$902K Sell
13,078
-795
-6% -$52.1K 0.24% 93
2025
Q1 		$940K Sell
13,873
-1,432
-9% -$85.7K 0.27% 87
2024
Q4 		$687K Sell
15,305
-6,559
-30% -$368K 0.21% 111
2024
Q3 		$1.37M Sell
21,864
-1,652
-7% -$96.4K 0.42% 58
2024
Q2 		$1.39M Sell
23,516
-1,417
-6% -$88.6K 0.45% 54
2024
Q1 		$1.99M Buy
24,933
+60
+0.2% +$4.58K 0.68% 38
2023
Q4 		$1.96M Buy
24,873
+3,093
+14% +$220K 0.73% 36
2023
Q3 		$1.52M Buy
21,780
+476
+2% +$33.7K 0.69% 38
2023
Q2 		$1.47M Buy
21,304
+453
+2% +$32.2K 0.66% 41
2023
Q1 		$1.55M Buy
20,851
+202
+1% +$16.9K 0.79% 34
2022
Q4 		$1.92M Buy
20,649
+302
+1% +$29.1K 1.03% 26
2022
Q3 		$1.94M Buy
20,347
+2
+0% +$198 1.13% 21
2022
Q2 		$1.89M Buy
20,345
+1,189
+6% +$116K 1.04% 22
2022
Q1 		$1.94M Sell
19,156
-853
-4% -$89.6K 0.93% 25
2021
Q4 		$2.06M Buy
+20,009
New +$1.85M 1.03% 23

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brown, Lisle/Cummings's CVS Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its CVS Health (CVS) stake by 0.76% in Q1 2026, buying an estimated $8.01K and bringing the position to 13,708 shares worth $985K. The position accounts for 0.25% of the portfolio, ranked #92.

Brown, Lisle/Cummings first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.06M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Brown, Lisle/Cummings held 13,708 shares of CVS Health worth $985K as of Q1 2026.
  • Brown, Lisle/Cummings bought 104 CVS Health shares in Q1 2026, an estimated $8.01K.
  • CVS Health made up 0.25% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #92 holding.
  • Brown, Lisle/Cummings first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's CVS Health position peaked at $2.06M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.